Skip to main content
OpenTrials
Recruiting

NCT Number: NCT03409159

Austrian Left Atrial Appendage Closure Registry

Left atrial appendage (LAA) occlusion (LAAC) has been introduced to treat patients with indication of oral anticoagulation (OAC) for atrial fibrillation (AF) with contraindication to OAC. This registry aims to document all LAAC procedures in Austria.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Medical University of Graz

Graz, 8036, Austria

Location status: Recruiting

Location contact

Daniel Scherr, Assoc.Prof. PD Dr.

CONTACT

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients who received LAAC in Austria

Exclusion criteria

  • Absence of informed consent

Treatment and study plan

LAAC

Device

Left atrial appendage closure

Primary outcomes

  1. Number of participants with successful left atrial appendage closure, as defined by European Society of Cardiology Guidelines

    Time frame: 30 days

Secondary outcomes

  1. Number of participants with death, stroke or bleeding

    Time frame: 5 years

  2. Number of participants with procedure-related adverse events

    Time frame: 30 days

Study contacts

Contact information is provided by the study sponsor or research team.

Daniel Scherr, Assoc.Prof. PD Dr.

CONTACT

[email protected]

+4331638512544

Sponsors and collaborators

Lead sponsor

Medical University of Graz

Other

Registry information

Important dates

Study start
2017
Primary completion
2025
Study completion
2025
First posted
Jan 24, 2018
Registry last updated
Nov 21, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.